Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01454297 · ClinicalTrials.gov registry record
Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
A clinical trial, sponsored by Multiple Myeloma Research Foundation.
- Completed
- Registry status
- 1,154
- Enrollment target
NCT01454297: Completed study, sponsored by Multiple Myeloma Research Foundation.
NCT01454297 is a clinical trial that has completed, run by Multiple Myeloma Research Foundation. The registered enrollment target is 1,154 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01454297 has completed, sponsored by Multiple Myeloma Research Foundation.
- COMPLETED
- Registry status
- 1,154 participants
- Enrollment target
Study Summary
The primary objective of this observational study is to identify the molecular profiles and clinical characteristics that define subsets of myeloma patients during the course of the disease.
Primary Outcome
Standard clinical and laboratory assessments. Genomic tests (DNA and RNA sequencing, etc.) on bone marrow aspirates obtained at baseline, suspected complete response, and relapse/progression.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,154 participants |
| Start Date | 2011-07 |
| Est. Completion | 2023-12-31 |
What the finished NCT01454297 record still lists
NCT01454297 is an observational study that tracks outcomes without assigning an intervention. Its 1,154 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01454297 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01454297 about?
NCT01454297 is a clinical study titled "Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile". The primary objective of this observational study is to identify the molecular profiles and clinical characteristics that define subsets of myeloma patients during the course of the disease.
What is the current status of trial NCT01454297?
This trial is currently completed. The enrollment target is 1,154 participants. The study started on 2011-07. Estimated completion is 2023-12-31.
Who is sponsoring clinical trial NCT01454297?
This trial is sponsored by Multiple Myeloma Research Foundation, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04474301 · 1,152 participants
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
- NCT05564026 · 1,151 participants
Molecular Epidemiology of Pediatric Germ Cell Tumors
- NCT06408181 · 1,150 participants · Phase 3
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
- NCT06528314 · 1,150 participants · Phase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia